О. Е. Акбашева

420 total citations
42 papers, 319 citations indexed

About

О. Е. Акбашева is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Immunology. According to data from OpenAlex, О. Е. Акбашева has authored 42 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cardiology and Cardiovascular Medicine, 18 papers in Epidemiology and 16 papers in Immunology. Recurrent topics in О. Е. Акбашева's work include Cardiovascular Disease and Adiposity (16 papers), Adipokines, Inflammation, and Metabolic Diseases (16 papers) and Biomarkers in Disease Mechanisms (10 papers). О. Е. Акбашева is often cited by papers focused on Cardiovascular Disease and Adiposity (16 papers), Adipokines, Inflammation, and Metabolic Diseases (16 papers) and Biomarkers in Disease Mechanisms (10 papers). О. Е. Акбашева collaborates with scholars based in Russia, United States and Germany. О. Е. Акбашева's co-authors include О. В. Груздева, О. Л. Барбараш, Yu. A. Dyleva, Е. Г. Учасова, В. Н. Каретникова, E. V. Belik, Daria A. Borodkinа, А. Н. Коков, В. Г. Матвеева and Л. В. Антонова and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Frontiers in Immunology.

In The Last Decade

О. Е. Акбашева

38 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
О. Е. Акбашева Russia 9 210 102 96 67 63 42 319
W.‐C. Voon Taiwan 7 321 1.5× 115 1.1× 181 1.9× 25 0.4× 83 1.3× 9 391
Paul Wadwa United States 4 160 0.8× 178 1.7× 46 0.5× 41 0.6× 85 1.3× 4 378
J. Otvos United States 5 108 0.5× 123 1.2× 78 0.8× 44 0.7× 34 0.5× 7 326
Vincenzo Pernice Italy 9 103 0.5× 78 0.8× 143 1.5× 33 0.5× 31 0.5× 25 299
Bo Kyeong Koo South Korea 7 54 0.3× 76 0.7× 126 1.3× 29 0.4× 74 1.2× 7 350
Yücel Arman Türkiye 9 60 0.3× 65 0.6× 91 0.9× 119 1.8× 70 1.1× 31 299
Christina Strack Germany 10 128 0.6× 69 0.7× 25 0.3× 22 0.3× 58 0.9× 21 238
P. Pemberton United Kingdom 7 130 0.6× 33 0.3× 110 1.1× 35 0.5× 61 1.0× 15 452
Basil Ammori United Kingdom 4 136 0.6× 46 0.5× 145 1.5× 12 0.2× 74 1.2× 7 239
Belén Adrio Spain 7 280 1.3× 101 1.0× 183 1.9× 10 0.1× 39 0.6× 14 357

Countries citing papers authored by О. Е. Акбашева

Since Specialization
Citations

This map shows the geographic impact of О. Е. Акбашева's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by О. Е. Акбашева with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites О. Е. Акбашева more than expected).

Fields of papers citing papers by О. Е. Акбашева

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by О. Е. Акбашева. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by О. Е. Акбашева. The network helps show where О. Е. Акбашева may publish in the future.

Co-authorship network of co-authors of О. Е. Акбашева

This figure shows the co-authorship network connecting the top 25 collaborators of О. Е. Акбашева. A scholar is included among the top collaborators of О. Е. Акбашева based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with О. Е. Акбашева. О. Е. Акбашева is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Спирина, Л. В., et al.. (2025). Clinical, Immunological, and Vesicular Markers in Sarcopenia and Presarcopenia. Frontiers in Bioscience-Landmark. 30(8). 42063–42063.
2.
Акбашева, О. Е., et al.. (2023). Alpha-2 macroglobulin activity in SARS-CoV-2 induced infection and in the post-COVID-19 period. Biomeditsinskaya Khimiya. 69(4). 240–247. 1 indexed citations
3.
Спирина, Л. В., et al.. (2022). Sars-Cov2 Induced Biochemical Mechanisms in Liver Damage and Intestinal Lesions. Indian Journal of Clinical Biochemistry. 38(4). 437–446. 4 indexed citations
4.
Груздева, О. В., Yu. A. Dyleva, E. V. Belik, et al.. (2021). Expression of adipocytokine in heart fat depots depending on the degree of coronary artery atherosclerosis in patients with coronary artery disease. Annals of the Russian academy of medical sciences. 76(2). 159–168. 1 indexed citations
5.
Барбараш, О. Л., О. В. Груздева, О. Е. Акбашева, et al.. (2020). Predictors of myocardial fibrosis and loss of epicardial adipose tissue volume in the long-term period after myocardial infarction. SHILAP Revista de lepidopterología. 25(2). 31–40. 3 indexed citations
6.
Груздева, О. В., et al.. (2019). Ghrelin Physiology and Pathophysiology: Focus on the Cardiovascular System. Kardiologiia. 59(3). 60–67. 6 indexed citations
7.
Borodkinа, Daria A., et al.. (2018). Leptin resistance: unsolved diagnostic issues. Problems of Endocrinology. 64(1). 62–66.
8.
Borodkinа, Daria A., et al.. (2018). Leptin resistance: unsolved diagnostic issues. Problems of Endocrinology. 64(1). 62–66. 8 indexed citations
9.
Учасова, Е. Г., О. В. Груздева, Yu. A. Dyleva, & О. Е. Акбашева. (2018). Epicardial adipose tissue: pathophysiology and role in the development of cardiovascular diseases. Bulletin of Siberian Medicine. 17(4). 254–263. 7 indexed citations
10.
Груздева, О. В., Daria A. Borodkinа, О. Е. Акбашева, et al.. (2017). Adipokine-cytokine profile of adipocytes of epicardial adipose tissue in ischemic heart disease complicated by visceral obesity. Obesity and metabolism. 14(4). 38–45. 4 indexed citations
11.
Груздева, О. В., et al.. (2017). Use of thrombin generation test for monitoring hemostasis in coronary bypass surgery. Clinical Hemorheology and Microcirculation. 66(1). 57–66. 2 indexed citations
12.
Груздева, О. В., Е. Г. Учасова, Yu. A. Dyleva, et al.. (2017). Relationship key factor of inflammation and the development of complications in the late period of myocardial infarction in patients with visceral obesity. BMC Cardiovascular Disorders. 17(1). 36–36. 9 indexed citations
13.
Груздева, О. В., О. Е. Акбашева, Yu. A. Dyleva, et al.. (2017). Adipokine and Cytokine Profiles of Epicardial and Subcutaneous Adipose Tissue in Patients with Coronary Heart Disease. Bulletin of Experimental Biology and Medicine. 163(5). 608–611. 68 indexed citations
14.
Груздева, О. В., Е. Г. Учасова, Yu. A. Dyleva, et al.. (2016). Early Effects of Treatment Low-Dose Atorvastatin on Markers of Insulin Resistance and Inflammation in Patients with Myocardial Infarction. Frontiers in Pharmacology. 7. 324–324. 14 indexed citations
15.
Барбараш, О. Л., О. В. Груздева, Е. Г. Учасова, et al.. (2016). Prognostic Value of Soluble ST2 During Hospitalization for ST-Segment Elevation Myocardial Infarction. Annals of Laboratory Medicine. 36(4). 313–319. 18 indexed citations
16.
Барбараш, О. Л., О. В. Груздева, Е. Г. Учасова, et al.. (2016). The role of adipose tissue and adipokines in the manifestation of type 2 diabetes in the long-term period following myocardial infarction. Diabetology & Metabolic Syndrome. 8(1). 24–24. 19 indexed citations
17.
Dyleva, Yu. A., О. В. Груздева, О. Е. Акбашева, et al.. (2015). SIGNIFICANCE OF STIMULATING GROWTH FACTOR ST2 AND NT-proBNP IN ASSESSMENT OF POSTINFARCTION REMODELING OF THE HEART. SHILAP Revista de lepidopterología. 4 indexed citations
18.
Груздева, О. В., et al.. (2015). CYTOKINE PROFILE IN VISCERAL OBESITY AND ADVERSE CARDIOVASCULAR PROGNOSIS OF MYOCARDIAL INFARCTION. SHILAP Revista de lepidopterología. 17(3). 211–211. 3 indexed citations
19.
Груздева, О. В., О. Е. Акбашева, Daria A. Borodkinа, et al.. (2015). RELATIONSHIP OF OBESITY PARAMETERS AND ADIPOKINES WITH THE RISK OF 2ND TYPE DIABETES DEVELOPMENT IN A YEAR AFTER MYOCARDIAL INFARCTION. SHILAP Revista de lepidopterología. 59–59. 8 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W.‐C. Voon Breakdown of academic impact, for papers by Paul Wadwa Breakdown of academic impact, for papers by J. Otvos Breakdown of academic impact, for papers by Vincenzo Pernice Breakdown of academic impact, for papers by Bo Kyeong Koo Breakdown of academic impact, for papers by Yücel Arman Breakdown of academic impact, for papers by Christina Strack Breakdown of academic impact, for papers by P. Pemberton Breakdown of academic impact, for papers by Basil Ammori Breakdown of academic impact, for papers by Belén Adrio
Rankless by CCL
2026